Individualised isotoxic accelerated radiotherapy and chemotherapy are associated with improved long-term survival of patients with stage III NSCLC: A prospective population-based study

Dirk De Ruysscher*, Angela van Baardwijk, Jessie Steevens, Anita Botterweck, Geert Bosmans, Bart Reymen, Rinus Wanders, Jacques Borger, Anne-Marie C. Dingemans, Gerben Bootsma, Cordula Pitz, Ragnar Lunde, Wiel Geraedts, Michel Oellers, Andre Dekker, Philippe Lambin

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

37 Citations (Web of Science)
3 Downloads (Pure)
Original languageEnglish
Pages (from-to)228-233
JournalRadiotherapy and Oncology
Issue number2
Publication statusPublished - Feb 2012


  • Non-small cell lung cancer
  • Radiotherapy
  • Chemotherapy
  • Stage III
  • Combined modality treatment
  • Individualised

Cite this